CRISPR gene editing: a revolution in progress
Prescriber
; 33(6):13-16, 2022.
Article
in English
| EMBASE | ID: covidwho-1913876
chimeric antigen receptor T-cell; CRISPR associated endonuclease Cas9; orphan drug; transcription activator like effector nuclease; zinc finger nuclease; apheresis; article; beta thalassemia; cell differentiation; cell therapy; clustered regularly interspaced short palindromic repeat; CRISPR Cas system; cystic fibrosis; DNA damage; gene editing; gene rearrangement; gene therapy; genomics; human; Human immunodeficiency virus; immune response; immune system; Influenza virus; nonhuman; RNA sequence; Severe acute respiratory syndrome coronavirus 2; thalassemia; tumor suppressor gene
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Prescriber
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS